Andrea V. Pontoriero

B C1282AFF, Argentina

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Emergence and Evolution of Triple Reassortant Highly Pathogenic Avian Influenza A(H5N1) Virus, Argentina, 2025.

Emergence and Evolution of Triple Reassortant Highly Pathogenic Avian Influenza A(H5N1) Virus, Argentina, 2025.

Journal: Viruses
Published: December 01, 2025

The re-emergence of vaccine-preventable diseases: The case of measles.

The re-emergence of vaccine-preventable diseases: The case of measles.

Journal: Revista Argentina de microbiologia
Published: July 09, 2025

Detection and characterization of highly pathogenic avian influenza A (H5N1) clade 2.3.4.4b virus circulating in Argentina in 2023.

Detection and characterization of highly pathogenic avian influenza A (H5N1) clade 2.3.4.4b virus circulating in Argentina in 2023.

Journal: Revista Argentina de microbiologia
Published: January 26, 2024

Cross-protection and cross-neutralization capacity of ancestral and VOC-matched SARS-CoV-2 adenoviral vector-based vaccines.

Cross-protection and cross-neutralization capacity of ancestral and VOC-matched SARS-CoV-2 adenoviral vector-based vaccines.

Journal: NPJ vaccines
Published: November 16, 2022

Lidocaine reinforces the anti-inflammatory action of dexamethasone on myeloid and epithelial cells activated by inflammatory cytokines or SARS-CoV-2 infection.

Lidocaine reinforces the anti-inflammatory action of dexamethasone on myeloid and epithelial cells activated by inflammatory cytokines or SARS-CoV-2 infection.

Journal: Biomedical journal
Published: May 17, 2022

Immune response to co-administration of measles, mumps, and rubella (MMR), and yellow fever vaccines: a randomized non-inferiority trial among one-year-old children in Argentina.

Immune response to co-administration of measles, mumps, and rubella (MMR), and yellow fever vaccines: a randomized non-inferiority trial among one-year-old children in Argentina.

Journal: BMC infectious diseases
Published: March 05, 2022

A DNA intercalating dye-based RT-qPCR alternative to diagnose SARS-CoV-2.

A DNA intercalating dye-based RT-qPCR alternative to diagnose SARS-CoV-2.

Journal: RNA biology
Published: May 10, 2021

Evaluation of RT-qPCR and Loop-Mediated Isothermal Amplification (LAMP) Assays for the Detection of SARS-CoV-2 in Argentina.

Evaluation of RT-qPCR and Loop-Mediated Isothermal Amplification (LAMP) Assays for the Detection of SARS-CoV-2 in Argentina.

Journal: Genes
Published: February 16, 2021

Development of a hyperimmune equine serum therapy for COVID-19 in Argentina.

Development of a hyperimmune equine serum therapy for COVID-19 in Argentina.

Journal: Medicina
Published: July 14, 2020

Genetic evolution of influenza viruses among selected countries in Latin America, 2017-2018.

Genetic evolution of influenza viruses among selected countries in Latin America, 2017-2018.

Journal: PloS one
Published: June 11, 2019

The characteristics and antigenic properties of recently emerged subclade 3C.3a and 3C.2a human influenza A(H3N2) viruses passaged in MDCK cells.

The characteristics and antigenic properties of recently emerged subclade 3C.3a and 3C.2a human influenza A(H3N2) viruses passaged in MDCK cells.

Journal: Influenza and other respiratory viruses
Published: January 26, 2017

Surveillance of antiviral resistance markers in Argentina: detection of E119V neuraminidase mutation in a post-treatment immunocompromised patient.

Surveillance of antiviral resistance markers in Argentina: detection of E119V neuraminidase mutation in a post-treatment immunocompromised patient.

Journal: Memorias do Instituto Oswaldo Cruz
Published: June 13, 2016
Showing 1-12 of 16

Last Updated: 09/26/2026